-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-effectiveness-of-interventions-intended-to-treat-anxiety-disorders-in-children-18-years-of-age-over-the-long-term-6-12-months-what-is-the-effectiveness-of-interventions-intended-to-prevent-the-development-of-anxie
March 07, 2013 - March 7, 2013
Download Topic Suggestion Disposition [PDF · 1.2 MB]
Briefly describe a specific question … Does your question include a comparison of different health care approaches? … What specifically motivated you to ask this question? … Potential Impact
How will an answer to your research question be used or help inform decisions for … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
March 01, 2021 - Primary birth outcome: cesarean delivery
Key
Question Intervention Findingsa Studies Incidence
Relative … Risk
(95% CI)
I2 for Pooled
Analysesb
Key
Question 1:
Prostaglandin
Outpatient
vs. … Primary fetal harms outcomes
Key
Question Intervention Outcome Findingsa Studies Incidence
Relative … Risk
(95% CI)
I2 for Pooled
Analysesb
Key
Question 1:
Prostaglandin
Outpatient
vs. … Risk
(95% CI)
I2 for pooled
analysesb
Key
Question 2:
Mechanical
Method
Outpatient
vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-summary.pdf
August 01, 2023 - For Key
Question 2 (re-irradiation), two RCTs and three NRSIs met inclusion criteria; for Key
Question … EBRT alone), nine RCTs and seven NRSIs; and for
Key Question 3c (EBRT plus another modality vs. the … Key Question 1 compared EBRT dose-fraction schemes and delivery of initial
palliative radiation for … Evidence for Key Question 2 on dose-fraction schemes and delivery for re-irradiation
was sparse. … Comparative evidence for Key Question 3 on EBRT in conjunction with additional
therapies was sparse.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/question-what-is-the-etiology-of-cryptorchidism-what-are-the-environmental-factors-maternal-smoking-maternal-diabetes-mellitus-etc-that-may-contribute-to-the-development-of-this-condition-question-what-is-the-ideal-diagnostic
May 10, 2010 - Question: What is the etiology of cryptorchidism? … Does your question include a comparison of different health care approaches? … Are there subgroups of patients that your question might apply to? … Does your question represent uncertainty for clinicians and/or policy-makers? … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surge
February 10, 2011 - 10, 2011
Download Topic Suggestion Disposition [PDF · 128.7 KB]
Briefly describe a specific question … The population in question is assumed to be patients who have had a thorough history and physical examination … What patients or group(s) of patients does your question apply to? … Describe the timeframe in which an answer to your question is needed. … Describe any health disparities, inequities, or impact on vulnerable populations your question applies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_executive.pdf
October 01, 2012 - of Key Question 2. … Note: KQ = Key Question. … Key Question 2b: Evidence About Integrative and
Consultative Models
This Key Question was not analyzed … Key Question 2b: Evidence About Integrative and
Consultative Models
This Key Question was not analyzed … Key Question 2a: Evidence About Types of Quality
Improvement
This Key Question was not analyzed for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_executive.pdf
July 01, 2012 - Key Question 2
What harms result from public reporting? … • Outcomes (specified for each Key Question)
– Key Question 1. … – Key Question 2. … – Key Question 3. … – Key Question 4.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/pico-populations-breastfeeding-infants-6-months-or-less-with-ankyloglossia-interventions-frenotomy-frenectomy-or-frenulotomy-comparators-breastfeeding-management-without-surgical-intervention-outcomess-successful-exclusive-br
March 14, 2013 - Does your question include a comparison of different health care approaches? … What patients or group(s) of patients does your question apply to? … Are there subgroups of patients that your question might apply to? … What specifically motivated you to ask this question? … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
January 01, 2013 - Key Question 1a. … Key Question 1b. … Key Question 1c. … Key Question 3. … Low
Key Question 1a HIV Mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - Eligibility criteria for studies for each Key Question are described in the full report. … Key Question 1 included 111 studies, Key Question 2 included 31 studies, Key
Question 3 included 99 … studies, Key Question 4 included 1 study, and Key Question 5
included 9 studies. … Key Question 2: Health Outcomes. … We also eliminated a Key Question on pharmacogenomics that was in the
original review.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-including-both-children-and-adult-subgroup-comparisons-with-type-1-diabetes-what-is-the-comparitive-differences-in-hba1c-levels-when-comparing-various-treatment-options-including-multiple-daily-injections-insulin
July 19, 2009 - Does your question include a comparison of different health care approaches? … What patients or group(s) of patients does your question apply to? … What specifically motivated you to ask this question? … Does your question represent uncertainty for clinicians and/or policy-makers? … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/migraine-patients-in-the-er-receive-various-iv-medications-from-different-er-doctors-within-the-physician-group-as-i-have-watched-particular-drug-combinations-given-to-my-patients-and-to-my-daughter-in-the-er-i-have-witnessed
May 24, 2009 - What patients or group(s) of patients does your question apply to? … Are there subgroups of patients that your question might apply to? … What specifically motivated you to ask this question? … Does your question represent uncertainty for clinicians and/or policy-makers? … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/in-patients-with-dementia-what-is-the-effectiveness-of-psychological-treatment-ie-non-pharmacological-eg-cognitive-or-behavioral-therapy-for-individuals-with-dementia-environmental-and-behavioral-interventions-to-address-beha
March 07, 2013 - March 7, 2013
Download Topic Suggestion Disposition [PDF · 1.2 MB]
Briefly describe a specific question … Does your question include a comparison of different health care approaches? … What specifically motivated you to ask this question? … Does your question represent uncertainty for clinicians and/or policy-makers? … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
October 01, 2011 - Does your question include a comparison of different health care approaches? … What patients or group(s) of patients does your question apply to? … Are there subgroups of patients that your question might apply to? … What specifically motivated you to ask this question? … Describe the timeframe in which an answer to your question is needed.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
April 16, 2020 - Public Reviewer 6
Anna Bono
Question 1 Personal anecdote including potentially private information … Public Reviewer 1
Karl Lorenz
Question 2 I find it quite problematic:
That you omit studies of “end … Public Reviewer 4
Jacob Marzalik,
American
Psychological
Association
Question 2 We appreciate the … Public Reviewer 6
Anna Bono
Question 4 Several studies in controlled settings have concluded that … Public Reviewer 7
Anonymous
Question 9 Thank you for this important contribution.
-
effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
May 19, 2010 - Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 3:
What subset of the … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 4:
What are the potential … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
January 01, 2023 - Agency for Healthcare Research and Quality (Rockville, Maryland, USA). 2023.
22
Key Question 1
What … 23
Key Question 1 – Population and Intervention Targets
Population
Postpartum (≤1 year after giving … group
Nonrandomized comparative studies (NRCSs) N≥30 per group
(prospective or retrospective)
Key Question … 1 – U.S. or Canada only
Key Question 2 – U.S. only
28
Evidence Identified
(92 studies)
Key Question … Key Question 3
What are the comparative effectiveness and harms of alternative magnesium sulfate (MgSO4
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 3: What subset of the population … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 4: What are the potential … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
November 01, 2023 - ACDF in patients with cervical spondylotic radiculopathy or myelopathy at one or
two levels (the Key Question … Main
findings are summarized by Key Question in Table A. … Summary of findings: cervical degenerative disease treatment
Key Question Comparison
Fusion;
Effect … Similar
(++)
AEs:
Moderate to Large,
favors laminoplasty
(+)
5
Key Question … Insufficient
Small,
favoring
PEEK
(+)
No
evidence Insufficient
6
Key Question
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - For Review Question 2, we will focus on identifying relevant measures that are included in
the Centers … including PSPs used and explanations of the rationale presented in the
studies we find for Review Question … For Review Question 8, we will identify publicly available patient safety toolkits developed
by AHRQ … For Review Question 2, we will focus on identifying relevant measures that are ... … For Review Question 8, we will identify publicly available patient safety toolkits developed by AHRQ